Clinical Trial Update: Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the combination of capecitabine and erlotinib with radiotherapy for non-operable advanced pancreatic cancer. The study is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Tarceva (erlotinib)
• Xeloda (capecitabine)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED